Eden Research (LON:EDEN) Announces Earnings Results

Eden Research (LON:EDEN) issued its quarterly earnings results on Wednesday. The company reported GBX (0.36) EPS for the quarter, Digital Look Earnings reports. Eden Research had a negative return on equity of 15.05% and a negative net margin of 44.31%.

Eden Research Trading Down 1.5%

Shares of EDEN traded down GBX 0.03 during mid-day trading on Friday, reaching GBX 2.17. The company had a trading volume of 218,368 shares, compared to its average volume of 582,820. Eden Research has a fifty-two week low of GBX 1.96 and a fifty-two week high of GBX 5. The firm has a fifty day simple moving average of GBX 2.68 and a 200-day simple moving average of GBX 3.14. The stock has a market cap of £17.42 million, a price-to-earnings ratio of -4.89 and a beta of 1.57. The company has a current ratio of 2.25, a quick ratio of 2.42 and a debt-to-equity ratio of 1.43.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.